Application of L-aspartic acid beta-hydroxamic acid in preparation of medicine for treating retinopathy of fundus retinopathy or premature infants
The invention provides application of L-aspartic acid beta-hydroxamic acid in preparation of a medicine for treating retinopathy of fundus retinopathy of a premature infant and belongs to the technical field of medicine. The L-aspartic acid beta-hydroxamic acid has the effects of protecting nerve re...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides application of L-aspartic acid beta-hydroxamic acid in preparation of a medicine for treating retinopathy of fundus retinopathy of a premature infant and belongs to the technical field of medicine. The L-aspartic acid beta-hydroxamic acid has the effects of protecting nerve retina and preventing and/or treating diabetic retinopathy or premature infant fundus retinopathy for the first time, and experiments are carried out by taking type II diabetic mice db/db mice as models and hypoxia-induced retinopathy models; it is found that the L-aspartic acid beta-hydroxamic acid can improve the functions of db/db mouse retina bipolar cells and non-long-process cells, protect nerve fiber layers and retinal ganglion cells, inhibit retinal microangiopathy and inhibit retinal angiogenesis in a hypoxia-induced retinopathy model. Therefore, the traditional Chinese medicine composition has effective prevention and treatment effects on diabetic retinopathy or fundus retinopathy of premature infants.
本发明提 |
---|